These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9873529)

  • 1. In vitro selection of phosphorothiolated aptamers.
    Jhaveri S; Olwin B; Ellington AD
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2285-90. PubMed ID: 9873529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
    Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
    Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.
    Fennewald SM; Rando RF
    J Biol Chem; 1995 Sep; 270(37):21718-21. PubMed ID: 7665590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
    Presta M; Statuto M; Isacchi A; Caccia P; Pozzi A; Gualandris A; Rusnati M; Bergonzoni L; Sarmientos P
    Biochem Biophys Res Commun; 1992 Jun; 185(3):1098-107. PubMed ID: 1378264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor binding and processing by human glioma cells.
    Murphy PR; Knee RS
    Mol Cell Endocrinol; 1995 Oct; 114(1-2):193-203. PubMed ID: 8674845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity.
    Heath WF; Cantrell AS; Mayne NG; Jaskunas SR
    Biochemistry; 1991 Jun; 30(22):5608-15. PubMed ID: 2036431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
    Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP
    Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotides containing degenerate bases. Synthesis and uses.
    Lin PK; Brown DM
    Methods Mol Biol; 1994; 26():187-206. PubMed ID: 8313003
    [No Abstract]   [Full Text] [Related]  

  • 9. The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2'-thio-LNA.
    Kumar R; Singh SK; Koshkin AA; Rajwanshi VK; Meldgaard M; Wengel J
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2219-22. PubMed ID: 9873516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immobilization of oligodeoxyribonucleotides with multiple anchors to microchips.
    Zhao X; Nampalli S; Serino AJ; Kumar S
    Nucleic Acids Res; 2001 Feb; 29(4):955-9. PubMed ID: 11160928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.
    Benimetskaya L; Tonkinson JL; Koziolkiewicz M; Karwowski B; Guga P; Zeltser R; Stec W; Stein CA
    Nucleic Acids Res; 1995 Nov; 23(21):4239-45. PubMed ID: 7501441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase contains two cooperating telomerase RNA molecules.
    Wenz C; Enenkel B; Amacker M; Kelleher C; Damm K; Lingner J
    EMBO J; 2001 Jul; 20(13):3526-34. PubMed ID: 11432839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cutaneous mast cells express basic fibroblast growth factor.
    Reed JA; Albino AP; McNutt NS
    Lab Invest; 1995 Feb; 72(2):215-22. PubMed ID: 7531794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine-aptamer complexes: a bipartite RNA site that binds the adenine nucleic base.
    Meli M; Vergne J; Décout JL; Maurel MC
    J Biol Chem; 2002 Jan; 277(3):2104-11. PubMed ID: 11705996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.
    Jellinek D; Green LS; Bell C; Lynott CK; Gill N; Vargeese C; Kirschenheuter G; McGee DP; Abesinghe P; Pieken WA
    Biochemistry; 1995 Sep; 34(36):11363-72. PubMed ID: 7547864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis.
    Li LY; Safran M; Aviezer D; Böhlen P; Seddon AP; Yayon A
    Biochemistry; 1994 Sep; 33(36):10999-1007. PubMed ID: 7522051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of a phosphorothioate RNA library during in vitro selection.
    Kawakami J; Sugimoto N
    Nucleic Acids Symp Ser; 1997; (37):201-2. PubMed ID: 9586069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate oligonucleotide-directed triple helix formation.
    Hacia JG; Wold BJ; Dervan PB
    Biochemistry; 1994 May; 33(18):5367-9. PubMed ID: 8180158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel combinatorial selection of phosphorothioate oligonucleotide aptamers.
    King DJ; Ventura DA; Brasier AR; Gorenstein DG
    Biochemistry; 1998 Nov; 37(47):16489-93. PubMed ID: 9843415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection of RNA molecules that bind specific ligands.
    Ellington AD; Szostak JW
    Nature; 1990 Aug; 346(6287):818-22. PubMed ID: 1697402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.